This study focuses on the critical challenge of early NPC detection, underscored by the observation that only 15.8% of newly diagnosed cases were identified at an early stage in our institution between 2019 and 2020. Current screening methods, especially those relying on EBV antibody detection, demo...
ORGANISM(S): Homo sapiens (Human)
